These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29282149)

  • 1. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
    Busse LW; McCurdy MT; Ali O; Hall A; Chen H; Ostermann M
    Crit Care; 2017 Dec; 21(1):324. PubMed ID: 29282149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
    Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED
    J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
    Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG
    Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter Observational Cohort Study of Angiotensin II in Shock.
    Smith SE; Newsome AS; Guo Y; Hecht J; McCurdy MT; Mazzeffi MA; Chow JH; Kethireddy S
    J Intensive Care Med; 2022 Jan; 37(1):75-82. PubMed ID: 33231111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
    Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N
    Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of angiotensin II-induced blood pressure and structural changes in Fischer 344 and Wistar Kyoto rats.
    Blanc J; Lacolley P; Laurent S; Elghozi JL
    Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):466-73. PubMed ID: 15236636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension.
    Polichnowski AJ; Griffin KA; Picken MM; Licea-Vargas H; Long J; Williamson GA; Bidani AK
    Am J Physiol Renal Physiol; 2015 Feb; 308(3):F252-60. PubMed ID: 25477472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats.
    Vyas SJ; Blaschak CM; Chinoy MR; Jackson EK
    Mol Cell Biochem; 2000 Sep; 212(1-2):121-9. PubMed ID: 11108143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic vascular effects of dietary sodium supplementation and angiotensin II administration.
    Csiky B; Simon G
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1275-82. PubMed ID: 9321816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilatory shock in the ICU and the role of angiotensin II.
    Wakefield BJ; Sacha GL; Khanna AK
    Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock.
    Allen JM; Gilbert BW
    Clin Ther; 2019 Dec; 41(12):2594-2610. PubMed ID: 31668356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Angiotensin II in Poisoning-Induced Shock-a Review.
    Chen A; Wong A
    J Med Toxicol; 2022 Apr; 18(2):145-154. PubMed ID: 35258848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein-cholesterol determines vascular responsiveness to angiotensin II in normocholesterolaemic humans.
    John S; Delles C; Klingbeil AU; Jacobi J; Schlaich MP; Schmieder RE
    J Hypertens; 1999 Dec; 17(12 Pt 2):1933-9. PubMed ID: 10703892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
    Bohlender J; Bader M; Ménard J; Nussberger J
    J Hypertens; 2012 Aug; 30(8):1597-605. PubMed ID: 22728903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of angiotensin II on pulse wave velocity in healthy humans.
    Rehman A; Rahman AR; Rasool AH; Naing NN
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):423-30. PubMed ID: 11680667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and behavioral effects of angiotensin II in conscious sheep.
    Breuhaus BA; Chimoskey JE
    Am J Physiol; 1990 May; 258(5 Pt 2):R1230-7. PubMed ID: 2337200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers.
    Tran D; Phoon S; Howes L
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):199-203. PubMed ID: 11881123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.